Apollomics Inc. (APLM) stock
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
$16.45−0.39 (-2.32%)
Close on Nov 18, 2026Market cap $36.13MP/E –Yield –
Apollomics net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Apollomics
Apollomics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?